Mr. Mehra et al., ALLOGRAFT AORTOPATHY - AN IN-VIVO STUDY OF DONOR AORTA INVOLVEMENT INCARDIAC ALLOGRAFT VASCULOPATHY, The American heart journal, 133(6), 1997, pp. 698-702
Limited histopathologic studies of failed cardiac allografts have demo
nstrated that cardiac allograft vasculopathy extends into the donor ao
rta; however, no study has examined the development of allograft aorti
c intimal proliferation in vivo in conjunction with coronary intimal h
yperplasia. By using simultaneous intracoronary and intraaortic ultras
ound, we studied 20 consecutive heart transplant recipients at 2.5 +/-
2.1 years after transplantation. The degree of coronary intimal thick
ening was strongly correlated with the development of intraaortic inti
mal hyperplasia (r = 0.90; p < 0.0001). Multivariate predictors of aor
tic intimal thickening included years after transplant (r = 0.47; p =
0.03), serum cholesterol level (r = 0.65, p = 0.003), and serum trigly
ceride level (r = 0.51; p = 0.03). Allograft aortopathy occurs in a si
milar manner to allograft coronary disease, thus providing support for
the notion that an immunologic stimulus operating across the allograf
t vascular bed may be responsible for the development of cardiac allog
raft vasculopathy. Furthermore, this investigation provides insight in
to the putative role of hyperlipidemia in allograft vascular disease.